Certara expands the simcyp™ simulator platform advancing biopharmaceutics, drug-drug interaction & biologic capabilities

Radnor, pa., april 01, 2025 (globe newswire) -- certara, inc. (nasdaq: cert), a global leader in model-informed drug development, has released a new version of the simcyp™ simulator for physiologically-based pharmacokinetic (pbpk) modeling.
CERT Ratings Summary
CERT Quant Ranking